Approval · Notice of Compliance 28347 · 2022
LITHANE: Notice of Compliance 28347
Issued June 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28347
- Date
- June 8, 2022
- Company
- Erfa Canada 2012 Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the labelling and convert the Product Monograph to the new Master template format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LITHANE | Not yet assigned | — |
Medicinal ingredients
- LITHIUM CARBONATE 150 MG per CAP
- LITHIUM CARBONATE 300 MG per CAP